American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2025

The American Academy of Child and Adolescent Psychiatry (AACAP) Pediatric Psychopharmacology Update Institute 2025 is an advanced educational program delivering the latest evidence-based knowledge on the use of psychotropic medications in children and adolescents. Presented by leading experts in psychiatry and pharmacology, this course blends cutting-edge research with practical, clinically relevant guidance to enhance prescribing practices, ensure patient safety, and improve treatment outcomes for young patients.

What You Will Learn

• Current best practices in pediatric psychopharmacology across a range of psychiatric disorders

• Evidence-based medication strategies for ADHD, mood disorders, anxiety disorders, psychotic disorders, and autism spectrum disorders

• Approaches to monitoring treatment response, managing side effects, and preventing adverse events

• Guidance on polypharmacy, special populations, and treatment-resistant cases

• Updates on novel pharmacologic agents and emerging therapeutic trends in child and adolescent psychiatry

Event Details

• Event: American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2025

• Format: Live virtual program with interactive Q&A sessions and on-demand access to recorded content

• Program Highlights: Expert-led lectures, real-world case discussions, and high-yield prescribing tips

• Topics Covered: Psychopharmacology principles, disorder-specific medication management, safety protocols, and integration with psychosocial interventions

Who Should Attend
Child and adolescent psychiatrists, general psychiatrists, pediatricians, psychiatric nurse practitioners, psychologists, and other healthcare professionals involved in prescribing or managing psychiatric medications for young patients.

Why Attend
This course provides a focused, up-to-date, and clinically applicable review of pediatric psychopharmacology. Attendees will leave equipped with the knowledge, skills, and confidence to make informed prescribing decisions that maximize therapeutic benefits while minimizing risks in the treatment of children and adolescents.

• Bipolar Disorder in Youth What is, What Isn’t, and how to Treat it.mp3
• Bipolar Disorder in Youth What is, What Isn’t, and how to Treat it.mp4
• Depression in North America What Works in Clinical Trials Versus What Works for the Teenager in Your Office.mp3
• Depression in North America What Works in Clinical Trials Versus What Works for the Teenager in Your Office.mp4
• Is Child Psychiatry Ready for the Master Observational Trial.mp3
• Is Child Psychiatry Ready for the Master Observational Trial.mp4
• Obsessive-Compulsive Disorder Pharmacology in 2025 Reviewing Basics and Dispelling Traditional Lore.mp3
• Obsessive-Compulsive Disorder Pharmacology in 2025 Reviewing Basics and Dispelling Traditional Lore.mp4
• Pediatric Drug Development in the United States.mp3
• Pediatric Drug Development in the United States.mp4
• Psychopharmacologic and Psychosocial Interventions to Address Mental Health Challenges in Autism.mp3
• Psychopharmacologic and Psychosocial Interventions to Address Mental Health Challenges in Autism.mp4
• Psychopharmacology for ODD Treating the Horse or the Cart.mp3
• Psychopharmacology for ODD Treating the Horse or the Cart.mp4
• Psychopharmacology in (not for) Autism Spectrum Disorder An Update.mp3
• Psychopharmacology in (not for) Autism Spectrum Disorder An Update.mp4
• Q&A Discussion.mp3
• Q&A Discussion.mp4
• Q&A Panel Discussion 1.mp3
• Q&A Panel Discussion 1.mp4
• Q&A Panel Discussion 2.mp3
• Q&A Panel Discussion 2.mp4
• Q&A Panel Discussion 3.mp3
• Q&A Panel Discussion 3.mp4
• Tics Tactics Navigating Pharmacotherapy in Pediatric Tourette’s Syndrome.mp3
• Tics Tactics Navigating Pharmacotherapy in Pediatric Tourette’s Syndrome.mp4
• Updates in ADHD Psychopharmacology.mp3
• Updates in ADHD Psychopharmacology.mp4